Rio Tinto 1st qtr iron ore output slips 3 pct

Gladys Abbott
April 21, 2017

(NASDAQ:DAVE) has declined 33.62% since September 9, 2016 and is downtrending. It has underperformed by 23.33% the S&P500.

The chief executive of the mining giant, Jean-Sebastien Jacques said in a statement obtained on Thursday, that the company remains in good stead moving forward. Rio Tinto plc has a 1-year low of GBX 1,604.50 and a 1-year high of GBX 3,685.00. Therefore 56% are positive.

Rio Tinto plc (LON:RIO) traded up 0.66% during midday trading on Thursday, hitting GBX 3050.50. Finally, Liberum Capital upped their price objective on Rio Tinto plc from GBX 2,130 ($26.53) to GBX 2,400 ($29.90) and gave the company a "sell" rating in a report on Thursday, January 26th. Glencore PLC had 361 analyst reports since July 23, 2015 according to SRatingsIntel. Canaccord Genuity maintained Rio Tinto plc (LON:RIO) on Wednesday, August 3 with "Buy" rating. Societe Generale upgraded the shares of RIO in report on Friday, October 2 to "Buy" rating.

On 8/4/2016 Rio Tinto plc announced a dividend of $0.45 with an ex dividend date of 8/10/2016 which will be payable on 9/22/2016. It has outperformed by 19.33% the S&P500. The firm's market capitalization is GBX 35.24 billion.

More news: Ex-NFL star Aaron Hernandez hangs himself in his prison cell

Iron ore and bauxite weren't the only commodities to record decreases in output compared with the previous quarter, with copper (37 per cent), coking coal (28 per cent), thermal coal (one per cent) and aluminium (seven per cent) all lower. It now has negative earnings. The company has market cap of $84.82 million. The Company's restaurants, which offer full table service, feature wood-smoked and off-the-grill entree favorites that fit into the barbeque category. The Copper & Diamonds segment has managed operations in Australia, Canada, Mongolia and the United States, and non-managed operations in Chile and Indonesia. 4 funds opened positions while 7 raised stakes. (NASDAQ:DAVE) for 20,000 shares.

Investors sentiment increased to 1.25 in 2016 Q4. (NASDAQ:DAVE) for 537,617 shares. Blackrock Advsr Lc accumulated 1,498 shares. Blackrock Institutional Tru Na invested in 228,917 shares. Barclays Public Limited Com invested 0% in Oramed Pharmaceuticals, Inc. (NASDAQ:DAVE) for 150,659 shares. Fincl Bank Of America De reported 917 shares. Cranbrook Wealth Mngmt owns 155 shares. As per Monday, March 7, the company rating was maintained by Bernstein.

Sign up here for free access to 7 articles per month + twice daily business email alerts.

Other reports by LeisureTravelAid

Discuss This Article